SCHEMBL19846957

SCHEMBL19846957

NCc1c(-c2ccccc2)oc2ccccc2c1=O

nearest known ligand 0.64

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ DDR2 Q16832 1/20 0.64
▸ KMT2A Q03164 5/20 0.59
▸ KDM4E B2RXH2 4/20 0.59
▸ MEN1 O00255 4/20 0.59
▸ CYP3A4 P08684 4/20 0.59
▸ LMNA P02545 3/20 0.59
▸ CA1 P00915 2/20 0.59
▸ CA2 P00918 2/20 0.59
▸ ALOX15 P16050 2/20 0.59
▸ MAPK1 P28482 2/20 0.59
▸ TP53 P04637 2/20 0.59
▸ CA12 O43570 1/20 0.59
▸ ABCB1 P08183 1/20 0.59
▸ CALM1 P0DP23 1/20 0.59
▸ AR P10275 1/20 0.59
▸ PKM P14618 1/20 0.59
▸ CYP1B1 Q16678 1/20 0.59
▸ CA9 Q16790 1/20 0.59
▸ ADORA3 P0DMS8 1/20 0.59
▸ CYP19A1 P11511 2/20 0.56

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Hydrochloric Acid SCHEMBL28357397 0.98 DDR2 (0.62) DDR2KMT2AKDM4EMEN1CYP3A4
SCHEMBL18079061 0.84 KMT2A (0.59) DDR2KMT2AKDM4EMEN1CYP3A4
SCHEMBL19846946 0.84 KMT2A (0.64) DDR2KMT2AKDM4EMEN1CYP3A4
SCHEMBL31319016 0.84 ABCG2 (0.60) DDR2KMT2AKDM4EMEN1CYP3A4
SCHEMBL5178618 0.84 ABCG2 (0.60) DDR2KMT2AKDM4EMEN1CYP3A4
SCHEMBL29169913 0.81 KMT2A (0.60) DDR2KMT2AKDM4EMEN1CYP3A4
SCHEMBL30699386 0.81 KDM4E (0.62) DDR2KMT2AKDM4EMEN1CYP3A4
SCHEMBL9019380 0.81 DDR2 (0.60) DDR2KMT2AKDM4EMEN1CYP3A4
SCHEMBL21318410 0.81 DDR2 (0.56) DDR2KMT2AKDM4EMEN1CYP3A4
SCHEMBL30672824 0.80 KMT2A (0.55) DDR2KMT2AKDM4EMEN1CYP3A4

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3266774-B1 SUBSTITUTED PYRIMIDINE COMPOUNDS AS PHOSPHATIDYLINOSITOL 3-KINASE DELTA INHIBITOR AND USE THEREOF NANJING SANHOME PHARMACEUTICAL CO LTD (CN) 2019-09-04 — — EP disclosed
US-20180037576-A1 SUBSTITUTED PYRIMIDINE COMPOUNDS AS PHOSPHATIDYLINOSITOL 3-KINASE DELTA INHIBITOR AND USE THEREOF NANJING SANHOME PHARMACEUTICAL CO., LTD. (CN) 2018-02-08 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20180037576-A1 SUBSTITUTED PYRIMIDINE COMPOUNDS AS PHOSPHATIDYLINOSITOL 3-KINASE DELTA INHIBITOR AND USE THEREOF PIK3CA, PIK3CD, PIK3CB DDR2 3289/4885KMT2A 3628/4885KDM4E 2353/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback